NCT02370199View on ClinicalTrials.gov

Peripheral Blood Flow Responses to Electromagnetic Energy

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Exposure to Man-made Visible Light
Interventions
DEVICE

670 nm light

670 nm light emitting diode will be placed 1 cm above the gastrocnemius muscle. The diode will not be in direct contact with the skin. Subjects will be exposed to 75 mW/cm2.

DRUG

octafluropropane

Octofluoropropane will be administered as a continuous infusion prior to the initiation of 670 nm light in order to measure skeletal muscle blood flow.

Trial Locations (1)

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER